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ABSTRACT Peptidoglycan (PG) is an essential structural component of the bacterial cell wall and maintains the integrity and
shape of the cell by forming a continuous layer around the cytoplasmic membrane. The thin PG layer of Escherichia coli resides
in the periplasm, a unique compartment whose composition and pH can vary depending on the local environment of the cell.
Hence, the growth of the PG layer must be sufficiently robust to allow cell growth and division under different conditions. We
have analyzed the PG composition of 28 mutants lacking multiple PG enzymes (penicillin-binding proteins [PBPs]) after growth
in acidic or near-neutral-pHmedia. Statistical analysis of the muropeptide profiles identified DD-carboxypeptidases (DD-
CPases) that were more active in cells grown at acidic pH. In particular, the absence of the DD-CPase PBP6b caused a significant
increase in the pentapeptide content of PG as well as morphological defects when the cells were grown at acidic pH. Other DD-
CPases (PBP4, PBP4b, PBP5, PBP6a, PBP7, and AmpH) and the PG synthase PBP1Bmade a smaller or null contribution to the
pentapeptide-trimming activity at acidic pH.We solved the crystal structure of PBP6b and also demonstrated that the enzyme is
more stable and has a lowerKm at acidic pH, explaining why PBP6b is more active at low pH. Hence, PBP6b is a specialized DD-
CPase that contributes to cell shape maintenance at low pH, and E. coli appears to utilize redundant DD-CPases for normal
growth under different conditions.
IMPORTANCE Escherichia coli requires peptidoglycan DD-carboxypeptidases to maintain cell shape by controlling the amount of
pentapeptide substrates available to the peptidoglycan synthetic transpeptidases. Why E. coli has eight, seemingly redundant
DD-carboxypeptidases has remained unknown.We now show that one of these DD-carboxypeptidases, PBP6b, is important for
cell shape maintenance in acidic growthmedium, consistent with the higher activity and stability of the enzyme at low pH.
Hence, the presence of multiple DD-carboxypeptidases with different enzymatic properties may allow E. coli to maintain a nor-
mal cell shape under various growth conditions.
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Bacteria are capable of growing in various environments ormedia that differ in the concentration of solutes, buffer com-
pounds, or ions or in osmolarity or pH. For example, the Gram-
negative bacterium Escherichia coli maintains robust growth un-
der conditions of high and low osmolarity, acidic to alkaline pH,
and minimal to nutrient-rich media (1). The cell buffers its cyto-
plasm by controlling the transport of molecules across its cyto-
plasmic membrane. However, the periplasm of E. coli is less buff-
ered and is affected more by the environment than the cytoplasm;
consequently, the pH of the periplasm is similar to that of the
growth medium. Furthermore, many molecules with a mass of
less than ~600 Da can diffuse into the periplasm via the outer
membrane porins (2). Hence, the biogenesis of essential cell en-
velope components, such as peptidoglycan (PG) or lipopolysac-
charide (LPS), must be sufficiently robust to enable the cell to
grow under different pH and osmolyte conditions. How this ro-
bustness is achieved is largely unknown.
PG comprises glycan chains that are connected by short pep-
tides, forming a net-like layer surrounding the cytoplasmic mem-
brane (3). The PG layer protects the cell from bursting due to its
turgor and maintains the structural integrity and the shape of the
cell. In E. coli, a multitude of enzymes and regulatory proteins
enlarge and remodel the PG layer when the cell is growing and
dividing (4). PG synthesis is the principal target of important
classes of antibiotics such as the -lactams (e.g., penicillin) and
glycopeptides (e.g., vancomycin).
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The penicillin-binding proteins (PBPs), which are targeted by
-lactams, play amajor role in the synthesis and remodeling of PG
(5). The synthetic PBPs are either bifunctional glycosyltrans-
ferases/transpeptidases (class A PBPs; in E. coli, PBP1A, PBP1B,
and PBP1C) or monofunctional transpeptidases (class B PBPs; in
E. coli, PBP2 and PBP3) (5, 6). The activities of the synthetic PBPs
are regulated by proteins associated with the intracellular cyto-
skeleton and, in E. coli, by outer membrane-anchored lipopro-
teins; PG synthesis is also coordinated with outer membrane con-
striction during cell division (7–12). According to a current
model, PG synthases participate in dynamic multienzyme com-
plexes, the elongasome and divisome, which facilitate PG growth
at the side wall and cell division site, respectively (4, 13, 14).
Purified PBP1A and PBP1B polymerize the PG precursor lipid
II in vitro (15, 16), but these PG synthases also exhibit hydrolytic
DD-carboxypeptidase (DD-CPase) activity, trimming pentapep-
tides to tetrapeptides, particularly in the presence of their cognate
Lpo activators and at low pH (17). It has been proposed that this
DD-CPase activity rescues a synthetic class A PBP from being
inactivated should it bind a donor peptide in the absence of an
available acceptor peptide (17). However, the main peptide-
trimming activity inE. coli stems from its eight classCPBPs,which
are DD-CPases and/or DD-endopeptidases (DD-EPases): PBP4
(18), PBP4b (19), PBP5 (20–22), PBP6a (formerly known as
PBP6) (20), PBP6b (23), PBP7 (24), AmpC (25), and AmpH (25,
26). The reason for this redundancy is unknown, but itmay reflect
the importance of DD-CPases in controlling the amount of pen-
tapeptide donor substrates for the transpeptidation reaction of
class A and B PBPs (27).
Many strains with multiple PBP deletions grow with few or no
morphological defects, revealing a remarkable robustness of the
PG syntheticmachinery, at least under laboratory conditions (28).
The DD-CPases are dispensable for the survival of E. coli, and,
with the exception of PBP5, the deletion of the corresponding
genes does not affect cell growth or morphology. The main DD-
CPase of E. coli is PBP5, because the deletion of its gene, dacA, and
of at least two other DD-CPase genes (or of mrcA, the PBP1A
gene) causes aberrant cell morphologies with kinks, bends, or
branches, and these defects can be corrected by ectopic expression
of PBP5 but not by expression of one of the other DD-CPases (21,
29). The importance of PBP5 might be a consequence of the tim-
ing and the level of its expression: PBP5 is expressed primarily
during early exponential growth, while PBP6a and PPB6b are ex-
pressed in the stationary and mid-exponential-growth phases, re-
spectively (23, 30, 31). Importantly, ribosome profiling showed a
significantly higher synthesis rate for PBP5 (~4,000 molecules
synthesized per generation; MOPS [morpholinepropanesulfonic
acid] complete medium, pH 7.4) than for PBP6, AmpC, and
AmpH (all three between 400 and 700 molecules) or for PBP4b
and PBP6b (both between 20 and 30 molecules) (32).
PBP5, PBP6a, and PBP6b are periplasmic proteins binding to
the cytoplasmic membrane by a C-terminal amphiphilic -helix,
which is important for the physiological function of PBP5 (33).
The membrane anchor is also important for PBP5 localization at
the cell division site, which depends on ongoing PG synthesis (34).
Adjacent to themembrane anchor, there is an elongated, -sheet-
rich domain, which appears to position the globular, catalytic do-
main at a fixed distance from the membrane (35–37). The region
from amino acid 200 to amino acid 219 around the KTGmotif of
the CPase domain is important for the cell shape maintenance
function of PBP5 (29). Although PBP5 and PBP6a have similar
structures, PBP6a exhibits DD-CPase activity that is 5 times lower
than that of PBP5 against the artificial substrate N,N-diacetyl-
Lys-D-Ala-D-Ala (AcLAA) and lacks activity against larger sub-
strates (38), presumably explaining why PBP6a cannot compen-
sate for the loss of PBP5 in the cell (22, 29, 33).
Here, we addressed the issue of why E. coli has so many redun-
dant PGDD-CPases. We have analyzed the PG composition of 28
multiple PBP mutants grown at pH 7.5 or 5.0. PBP6b is the pre-
dominantCPase at acidic pH, consistentwith our findings that the
expression of PBP6b is enhanced at low pH and that PBP6b con-
tributes to proper cell shape under this condition. PBP6b is more
active and more stable at low pH than at neutral pH, and we
present its crystal structure. Taken together, our data indicate that
PBP6b is a DD-CPase specialized for growth at acidic pH and that
the redundancy of DD-CPases ensures that sufficient activity is
available under various pH conditions.
RESULTS
Muropeptide analysis reveals PBP activities in cells growing at
different pH values. To provide insight into the roles of E. coli
PBPs that, as yet, have no known biological function, we deter-
mined the compositions of PG muropeptides from 28 E. coli
strains that lacked various combinations of PBPs. Each strain was
grown at both pH 5.0 and pH 7.5, and the results were analyzed to
determine the changes associatedwith the presence and absence of
different PBPs (see Table S1 in the supplementalmaterial). In cells
grown at pH 7.5, the presence of PBP5, PBP6b, or PBP7 was asso-
ciated with higher DD-CPase activity; that is, the quantity of
pentapeptide side chains in PG decreased while that of the tet-
rapeptides increased (see Fig. S1A and B and Table S1 in the sup-
plemental material). PBP5 is the classic PG DD-CPase (27), and
the muropeptide composition of strains containing PBP5 was
consistent with this activity. Although PBP6a is most closely re-
lated to PBP5, PBP6a exhibited little or no DD-CPase activity in
vitro (38). Consistent with these results, PBP6a was associated
with only slight changes in muropeptide composition in cells
grown at pH 7.5 or pH 5.0 (see Fig. S1 and Table S1). In fact, the
presence of PBP6a was associated with muropeptide changes that
were the opposite of those expected of a DD-CPase; in isogenic
strains, the presence of PBP6a increased the percentage of penta-
peptides (by up to 15%) and decreased the percentage of tetrapep-
tides (by asmuch as 12%) (see Fig. S1A andB andTable S1). These
results were exactly the opposite of those associated with PBP5.
Thus, PBP6a appears to be inactive as a DD-CPase and may even
protect some pentapeptides from being cleaved.
In strains lacking PBP5, PBP4 appeared to be a strong DD-
CPase at pH 7.5 (see Fig. S2A and B and Table S1). The DD-CPase
activity associated with PBP7 was a surprise, because this enzyme
is an endopeptidase (24) forwhich noDD-CPase activity had been
described previously until a recent report describing its ortho-
logue in Pseudomonas aeruginosa was published (39). Finally, the
presence of PBP1B was also associated with weak DD-CPase ac-
tivity at pH 5.0 (see Fig. S1C and D, S2C and D, and Table S1),
which is consistent with the recently reported DD-CPase activity
of the purified enzyme (17).
PBP6b is themajorDD-CPase at low pH. PBP6b (also known
as DacD) is another putative DD-CPase in E. coli, with 47% se-
quence identity to both PBP5 and PBP6a (23). The biological role
of PBP6b is unknown, and previous experiments have identified
Peters et al.
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only one phenotype associated with its absence, a delay in the
biogenesis of the GOB-18 metallo--lactamase (40). When
PBP6b was present in cells grown at pH 5.0, pentapeptides disap-
peared and tetrapeptides appeared, indicating that PBP6b exhib-
ited strong DD-CPase activity at this pH (Fig. 1; see also Fig. S1C
and D and Table S1 in the supplemental material). In fact, the
activities of PBP4, PBP5, and PBP7 disappeared at pH 5.0, and
PBP6b became by far the most prominent DD-CPase, with in-
ferred activity equivalent to that of PBP5 at pH 7.5 (see Fig. S2C
and D and Table S1).
In order to better characterize the activity of PBP6b in vivo, we
next compared themuropeptide composition of E. coli SKCS77-1,
a strain that lacks all class C PBPs and the bifunctional class A
PBP1A, to that of an isogenic mutant, SKCS72-1, which contains
PBP6b (Fig. 1; see also Table S1 in the supplemental material).
Pentapeptides were highly abundant in SKCS77-1 muropeptides
at both pH values (Fig. 1), consistent with the absence of all DD-
CPases in this strain. In contrast, some DD-CPase activity of
PBP6b was observed at pH 7.5 in SKCS72-1 (Fig. 1; see also Ta-
ble S1). At this pH, in the presence of PBP6b, the fraction of
pentapeptides decreased by a quarter (from ~56% to ~42%),
while the fraction of tetrapeptides increased by almost one-third
(from ~38% to ~50%). Interestingly, the tetrapeptide-richmuro-
peptide profile of SKCS72-1 was restored by growth at pH 5.0
(Fig. 1) to the lower levels typical for the wild-type strain. The
fraction of pentapeptides decreased by 90% (from~53% to~5%),
and the fraction of tetrapeptides doubled (from ~40% to ~82%)
(see Table S1), consistent with a significant increase in PBP6b
DD-CPase activity at pH 5.0.
Overall, these data show that PBP6b was an active DD-
CPase in cells grown at pH 5.0, under which condition it
trimmed the majority of pentapeptides, though it was also
present and partially active at pH 7.5 when all other LMWPBPs
were absent.
dacD transcription and translation increase at pH 5.0. The
enhanced in vivo DD-CPase activity of PBP6b at pH 5.0 could be
explained by an increase in PBP6b protein levels and/or by an
increase in the specific activity of PBP6b at this pH. Indeed, ribo-
some profiling indicates that E. coli MG1655 produces only 29
molecules of PBP6b per generation when grown in a richmedium
or only 6 molecules per generation when grown in a minimal
MOPS medium at pH 7.4 (32). Hence, it was feasible that PBP6b
was not produced at pH 7.5 but wasmade in a substantial quantity
only at pH 5.0. We therefore measured the influence of pH on
dacD expression by replacing the chromosomal dacD open read-
ing frame with the superfolder GFP gene (sfgfp), thereby placing it
under control of the native dacD promoter and ribosome binding
site. The fusion was subcloned into the CS109 parental strain and
into the CS315-1 PBP mutant (PBP4, PBP5, and PBP7). When
the sfGFP signal per cell was quantified by flow cytometry (Ta-
ble 1), there was little difference in the amounts of sfGFP pro-
duced when either strain was grown at pH 7.5, even when the cells
contained the dacD-sfgfp reporter fusion (Table 1; pH 7.5 values).
Therefore, very little sfGFP (and, by extension, PBP6b) was pro-
FIG 1 PBP6b is active in cells growing at pH 5.0. (A) Muropeptide profiles of E. coli wild-type strain CS109 and of two PBPmutants, SKCS72-1 (PBP6b) and
SKCS77-1 (PBP6b), grown at pH 7.5 or 5.0. SKCS77-1 lacks PBP1A, PBP4, PBP4B, PBP5, PBP6a, PBP7, AmpH, AmpC, and PBP6b; SKCS72-1 lacks PBP1A,
PBP4, PBP4B, PBP5, PBP6a, PBP7, AmpH, and AmpC. The main muropeptides are numbered. Bar, 500 mAU. (B) Names and structures of the muropeptides
numbered in panel A. GlcNAc, N-acetylglucosamine; MurNAc(r), reduced N-acetylmuramic acid; m-Dap, mesodiaminopimelic acid.
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duced at pH 7.5. At pH 5.0, control strains without the sfGFP
fusion exhibited slightly higher background fluorescence
(Fig. 2A, dacD-positive [dacD] frames; Table 1, pH 5.0, lines 1
and 3). In contrast, when the latter two strains carried the
dacD-sfgfp reporter fusion, the amount of sfGFP increased no-
ticeably (Fig. 2A). When background fluorescence is sub-
tracted, the calculated amount of GFP increases approximately
25- to 40-fold in both SKCS143-1 (the wild type) and
SKCS144-1 (the triple PBP mutant) (Table 1, pH 5.0, lines 2
and 4). Thus, growth at pH 5.0 strongly induced gene expres-
sion from the dacD promoter.
To determine whether the increase in dacD transcription also
led to an increase in PBP6b protein levels at pH 5.0, FLAG gene
sequences were fused to the 3= termini of the chromosomal genes
encoding PBP6b (dacD) and PBP5 (dacA). Both PBP6b-FLAG
and PBP5-FLAG behaved like wild-type proteins in that their ex-
pression in the CS109 parent caused no growth or morphological
phenotypes, while their expression in the CS315-1 PBP mutant
complemented the morphological defects of this strain (data not
shown). Neither untagged PBP5 nor PBP6b bound the anti-FLAG
antibody at either pH (Fig. 2B, lanes 1, 2, 7, and 8). About 25% less
PBP5-FLAG was produced in cells grown at pH 5.0 than in cells
grown at pH 7.5 (Fig. 2B, lanes 3 and 4), suggesting either that
dacA expression was inhibited or that PBP5 was less stable at
pH 5.0. In contrast, the PBP6b-FLAGbandwas present only when
the parent or themutant was grown at pH 5.0 (Fig. 2B, lanes 6 and
10) and was undetectable in cells of either strain grown at pH 7.5
(Fig. 2B, lanes 5 and 9), consistent with the low copy number
determined by ribosome profiling (32). The amount of PBP6b-
FLAG at pH 5.0was ~22%of the amount of PBP5 in cells grown at
pH 7.5 (Fig. 2B and data not shown). Since PBP5 is present in 800
to 4,000 copies per cell (32, 41), we estimate that 200 to 800 copies
of PBP6b were produced at pH 5.0. Given that there are 6 to 30
copies of PBP6b per cell at pH 7.5 (32), the amount of PBP6b
expanded by 30- to 100-fold in cells grown at pH 5.0. Transcrip-
tion increased by about 25- to 40-fold (as described above), so
bothmethods corroborate a similar and significant increase in the
levels seen with PBP6b at pH 5.0. In addition, there was ~50%
more PBP6b in the triple PBP mutant CS315-1 (Fig. 2B, lane 10),
suggesting that PBP6b might be upregulated in the absence of
PBP4, PBP5, and PBP7. In summary, the production of PBP6b
was below detectable levels when cells were grown at pH 7.5, but
the protein was expressed inmuch greater amounts in cells grown
at pH 5.0, consistent with the idea that low pH induces dacD gene
expression and PBP6b production.
PBP6b has higher activity at acidic pH. We purified PBP6b
and PBP5 (Fig. 3A) lacking their signal peptides but containing an
N-terminal oligohistidine tag, which was subsequently removed
by proteolytic cleavage. Both proteins contained the -helical
membrane anchor near the C terminus. We used several assays to
TABLE 1 DacD, transcription increases at pH 5.0a
Strain PBPs deleted PdacD:: sfGFP
Mean GFP
intensity/cell (AU)
pH 7.5 pH 5.0
CS109 (wt) None  68 129
SKCS143-1 None  72 247
CS315-1 4, 5, 7  93 137
SKCS144-1 4, 5, 7  107 257
a Strains with and without PdacD::sfGFP were grown in Penassay broth at pH 7.5 and
pH 5.0. For each strain, the GFP signal intensity of 100,000 cells was measured by
fluorescence-activated cell sorter (FACS) analysis and is reported in arbitrary units
(AU). An increase in GFP intensity denotes increased dacD transcription. The
experiment was repeated at least twice, with equivalent results.
FIG 2 Increased transcription and translation of dacD at pH 5. (A) dacD transcription. Chromosomal dacD was replaced with the gene encoding superfolder
GFP (sfGFP) and placed under control of the dacD promoter (PdacD::sfGFP). The wild-type parent (CS109) and a mutant lacking PBP4, PBP5, and PBP7 (457
strain; CS315-1) with and without dacD::sfGFP were grown to an OD600 of 0.7 to 0.8 in Penassay broth at pH 5.0 and observed for fluorescence. (B) Production
of PBP6b and PBP5. Genes encoding C-terminal FLAG fusions to PBP5 (PBP5-FLAG) or PBP6b (PBP6b-FLAG) were inserted into their natural chromosomal
positions. Cells with and without the fusions were grown in Penassay broth at pH 7.5 and pH 5.0, and the FLAG-tagged proteins from membrane fractions
(10 g) were separated by SDS-PAGE and detected by Western blotting, using HRP-conjugated anti-FLAG antibody. wt, wild-type E. coli CS109; 457, E. coli
CS315-1 (a mutant lacking PBP4, PBP5, and PBP7). Lanes 1 and 2, wild-type cells; lanes 3 and 4, wild-type cells expressing PBP5-FLAG; lanes 5 and 6, wild-type
cells expressing PBP6b-FLAG; lanes 7 and 8,457mutant cells only; lanes 9 and 10,457mutant cells expressing PBP6b-FLAG.Cells were grown at either pH7.5
or pH 5.0, as indicated above the lanes.
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test the activity of purified PBP6b under different pH conditions.
First, we measured the binding of the fluorescent penicillin deriv-
ative Bocillin-FL. PBP6b was incubated with Bocillin-FL at 37°C
and pH 5.0 or pH 7.5 for different time periods, followed by gel
electrophoresis and fluorescence detection of the PBP6b-Bocillin
FL complex. PBP6b bound Bocillin-FL significantly faster at
pH 5.0 than at pH 7.5 (Fig. 3B).
Second, we assayed the DD-CPase activities of PBP6b and
PBP5 against pentapeptide-rich PG from E. coliCS703-1 at pH 5.0
and 7.5. The PG was incubated with increasing concentrations of
PBP6b or PBP5 for 1 h at 37°C, followed by digestion with the
muramidase cellosyl and analysis of the muropeptide profile by
high-pressure liquid chromatography (HPLC); representative
chromatograms are shown in Fig. S3 to S4 in the supplemental
material. PBP6b produced significant amounts of tetrapeptides in
a concentration-dependent manner at pH 5.0 but not at pH 7.5
(Fig. 3C; see also Fig. S3), consistent with the enhanced activity of
PBP6b in cells growing at acidic pH (Fig. 1). In contrast, PBP5was
active at both pH values, with slightly higher activity at pH 5.0
than at pH 7.5 (Fig. 3C; see also Fig. S4). The activity of PBP5 was
greater against monomeric pentapeptides than against dimeric
(cross-linked) tetrapentapeptides, whereas PBP6b had similar ac-
tivities againstmonomers and dimers. To determine if PBP6b and
PBP5 act on muropeptides with a Gly residue at position 5 (in-
stead of D-Ala), which are rare in E. coli but abundant in other
species such asCaulobacter crescentus, each enzymewas incubated
with pentapeptide- and glycine-rich PG from C. crescentus at dif-
ferent pH values, followed by muropeptide analysis; representa-
tive chromatograms are shown in Fig. S5A. PBP6b showed signif-
icant activity only against the C. crescentus PG at pH 5.0, whereas
PBP5 was active at both pH values (see Fig. S5B), which was sim-
ilar to what we observed for E. coli PG (Fig. 3C). PBP6b and PBP5
FIG 3 Activities of PBP6b and PBP5. (A) Purified PBP6b and PBP5 (2.7 g) were analyzed by SDS-PAGE and Coomassie staining. (B) Increased Bocillin
binding of PBP6b at pH 5.0. Purified PBP6b was incubated with the fluorescent penicillin derivative Bocillin for different time periods at 37°C and pH 5.0 or
pH 7.5. The intensities of the fluorescence signals were quantified with ImageJ and are given relative to the value at pH 5.0 (45 min). (C) Activity of PBP6b and
PBP5 against pentapeptide-rich PG from E. coli CS703-1 at pH 7.5 or 5.0. PG was incubated with different concentrations of PBP6b and PBP5, followed by
digestion with cellosyl, reduction, and muropeptide analysis. Only changes in the main substrate (Penta, TetraPenta) and product (Tetra, TetraTetra) muro-
peptides are summarized. Representative chromatograms are shown in Fig. S3 and S4 in the supplemental material. The values are means standard deviations
(SD) of the results of 3 independent experiments.
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were both less active against glycine-containing pentapeptides
(Penta-Gly5 and TetraPenta-Gly5) than against normal pentapep-
tides (Penta and TetraPenta), which is consistent with the obser-
vation that the low levels of Gly-containing pentapeptides were
similar in strains with or without PBP6b or PBP5 grown at both
pH values (see Table S1).
Crystal structure of E. coli PBP6bC. To rationalize the mo-
lecular basis of the pH dependency of the DD-CPase activity of
PBP6b, its crystal structure was solved by molecular replacement
using the apo structure of PBP5 (PDB identifier [PDBid] 1NZO)
as the search model (37) and refined to a resolution of 2.4 Å. Data
collection details and model refinement statistics are summarized
in Table S3 in the supplemental material. The construct that
yielded crystals suitable for structure determination (PBP6bC)
lacked the N-terminal 21 residues of the signal peptide and the
C-terminal 14-residue membrane anchor. The structure of
PBP6bCcomprises two domains; theCPase domain is formed of
residues Glu2 to Thr262, whereas the C-terminal domain com-
prises Thr263 to Thr346, with two breaks in themodeled polypep-
tide chain, between residues Lys272 and Asp287 and between res-
idues Leu317 and Pro320, because of disorder. The crystals
contain two PBP6bC copies per asymmetric unit, which can be
superimposed with the root mean square deviation (RMSD) of
0.3 Å on 324 aligned C atoms. There is no significant difference
in the relative dispositions of the two domains in the two mole-
cules in the asymmetric unit, therefore, the two chains can be
considered to be essentially identical.
Given the 48% sequence identity between the PBP6b and PBP5
(see Fig. S6 in the supplemental material), it is unsurprising that
the structures of PBP6bC and various PBP5C constructs su-
perimpose well. A global superimposition of 292 Cs yields an
RMSD value of 1.4 Å, indicating that the relative dispositions of
the two domains in each PBP are the same. The CPase domains
superimpose on 256 aligned C atoms with an RMSD of 1.1 Å,
whereas the C-terminal domains superimpose with an RMSD of
2.2 Å on 70 aligned Cs. The C-terminal domains share sequence
identity of 34%, consistent with their poorer structural alignment.
Furthermore, the C-terminal domain in PBP6bC is relatively
poorly ordered, with an average B factor on main chain atoms of
59.3 Å2 compared to 31.5 Å2 for the CPase domain, whereas the B
factor distributions for PBP5 (PDBid 1NZO) are more even, with
equivalent values of 29.9 Å2 and 32.1 Å2, respectively. Despite
cocrystallization of PBP6bCwith 2 mMdiacetyl-L-Lys-D-Ala-D-
Ala, there is no evidence of bound product from the pseudosub-
strate. The crystal packing involves the region immediately sur-
rounding the PBP6bC active site (Ser42) such that the observed
crystal packing would likely have been disfavored had the product
of the CPase reaction been bound.
Molecular explanation of the pH dependency on activity for
E. coli PBP6b. Does the structure of PBP6bC explain the pH
dependency on enzyme activity? The nature of the residues in the
immediate vicinity of Ser42 compared to PBP5, which does not
display the same pH effects, may provide the answer to this ques-
tion. Of all the residues within 10 Å of the Ser42 side chain hy-
droxyl, all but one are invariant between PBP6bC (Asn39) and
PBP5 (Asp49). While asparagine does not normally contribute
directly to catalysis, unlike aspartate, which can act as a general
acid or a base, the amide-imide tautomerization of Asn92 in the
glycoside hydrolase family 45 endocellulase has recently been de-
scribed (42). In the endocellulase, Asn92 is on one side of the
active site groove, 6 Å away from the general acid Asp114 on the
other side of the groove that accommodates the cellulose sub-
strate. As with PBP6b, there is strong dependency on acidic pH for
activity of the wild-type cellulase, which is eliminated bymutating
Asn92 to aspartate. Asn39 in PBP6bC is 9 Å away from the nu-
cleophilic Ser42, and, should the CPase reaction proceed using a
Grotthuss-like proton relay mechanism similar to that of the
GH45 cellulase (42), residues His214 and Ser216 are likely inter-
mediates between Ser42 and Asn39. Perhaps this mechanism is
disfavored at neutral pHor in PBP5, whereHis216 andAsp218 are
the intermediaries between Ser44 and Asp41.
Alternatively, the pHdependency of PBP6bmight be explained
by a change either in protein stability and/or in the Km for its
substrate as a function of pH. Consequently, the melting temper-
ature (Tm) for PBP6b and PBP6bC was obtained by differential
scanning fluorimetry (DSF) and by circular dichroism-based
thermal melt analysis. For both proteins, bothmethods revealed a
16°C difference in Tm, 57.5°C at pH 5.0 versus 41.5°C at pH 7.4
(Fig. 4C and data not shown). For PBP5, DSF was unsuccessful
because the presence of theTritonX-100 detergent used in protein
purification led to unacceptable background fluorescence. Circu-
lar dichroism-based thermal melts yielded Tm values of 58.4°C
and 51.2°C at pH 5.0 and 7.4, though precipitation of the protein
during the course of the experiment hindered the collection of
ideal data. Nevertheless, the similarity of the Tm value at different
pH values suggests that PBP5 is less prone to instability at pH 7.4
than PBP6b.
To complement the protein stabilitymeasurements, the PBP6b
DD CPase activity was tested against diacetyl-L-Lys-D-Ala-D-Ala,
and the kinetic parameters were measured under different pH
conditions in a spectrophotometric D-alanine release assay. The
Vmax and kcat values were similar at the two pH values (Table 2)
and were consistent with published values measured at pH 8.5
(43). However, the Km value was 18-fold lower at pH 5.0 than at
pH 7.5, which is consistent with the increased binding of Bocillin
FL at this pH, indicating that the increased activity of PBP6b
against pentapeptide-rich PG at acidic pH (Fig. 3) was due to both
enhanced protein stability and enhanced substrate binding affin-
ity.Without elucidation of structures of PBP6b at both pH values,
however, a molecular explanation of the pH dependency on pro-
tein stability and Km cannot be provided.
PBP6b, but not PBP5 or PBP6a, preserves wild-type mor-
phology at low pH. In the absence of PBP5, E. coli cells are abnor-
mally shaped and their peptidoglycan contains more pentapep-
tides (21, 22, 44). However, those observations were made in cells
grown in a richmediumat pH7.0 to 7.5. Aswe showabove, PBP6b
cleaves pentapeptides more efficiently at pH 5.0, making it possi-
ble that PBP6b might replace PBP5 to produce cells having wild-
type morphology under those conditions. To test this idea, cells
lacking different PBPs were grown at pH 7.5 and 5.0, and altera-
tions in cell shape were quantified by means of flow cytometry.
As described before (21, 22), E. coli mutants lacking PBP5 ex-
hibited aberrantmorphologies when grown at pH7.5, particularly
in the absence of other low-molecular-weight (LMW)PBPs (com-
pare Fig. 5A to the mutant cell shapes in Fig. 5B to I). These shape
changes produced large rightward shifts in the forward light scat-
ter of cell populations (Fig. 5S) and increased the average mean
size of these cells (expressed in arbitrary units [AU]) (Fig. 5U).
Themagnitude of these alterations paralleled the subjective degree
of morphological change as determined by microscopy. Notably,
Peters et al.
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at pH 7.5, the presence or absence of PBP6b influenced cell shape
very little (~10% variance) (Fig. 5B to I and U), reinforcing the
conclusion that PBP5 is themajor low-molecular-weight PBP that
maintains cell shape.
In sharp contrast, when grown at pH 5.0, mutants lacking
PBP5 but containing wild-type PBP6b produced cells with almost
normal rod shapes (Fig. 5K and M and Q). These cells had popu-
lation distributions (Fig. 5T, green peaks) and mean sizes
(Fig. 5U) that were near or slightly smaller than those of the wild-
type parent. However, strains lacking both PBP5 and PBP6b con-
tinued to produce morphologically aberrant cells (Fig. 5L and N
and R). Compared to the results seen with matched strains con-
taining wild-type PBP6b (Fig. 5T, green lines), the population
distributions of cells lacking PBP5 and PBP6b shifted significantly
rightward (Fig. 5T, red lines), and the mean cell sizes increased in
themutants (Fig. 5U). In short, in the absence of PBP5, PBP6bwas
required to maintain the normal rod shape of E. coli grown at
pH 5.0.
We next tested the function of PBP6b and closely related DD-
CPases by producing these proteins from plasmid-borne clones.
The host was E. coli strain SKCS127-1, a mutant with visibly ab-
errant morphology, whose cells exhibited short branches, kinks,
and buds (see, e.g., Fig. 6A andH). At both pH 7.5 and pH 5.0, the
population distribution of SKCS127-1 (Fig. 6O and P, solid green
lines) skewed to the right of CS109 (Fig. 6O and P, wt), and the
mean cell size increased (Fig. 6Q). Compared to the uncomple-
mented strain (Fig. 6H), supplying PBP6b to SKCS127-1 restored
wild-type shape to cells grown at pH 5.0 (Fig. 6I), and the popu-
lation distribution moved leftward (Fig. 6P, solid red line), to
become equivalent to that of nonmutated E. coli (Fig. 6P, solid
black line). In addition, the 3028 AU mean cell size of the parent
(Fig. 6Q, pH 5.0, vector) decreased to 2,035 AU in the comple-
mented strain (Fig. 6Q, pH 5.0, 6b), equivalent to the 2,055 AU
of nonmutated cells (Fig. 6Q, pH 5.0, wt). Thus, PBP6b effectively
replaced the function of PBP5 in cells grown at pH 5.0, the condi-
tion under which PBP6b is most active.
Restoring PBP6b also returned the mutant to a more normal
rod shape at pH 7.5 (compare Fig. 6B to Fig. 6A). The population
distribution of the complemented strain (Fig. 6O, solid red line)
was closer to that of wild-type cells (Fig. 6O, black line) than that
of cells lacking PBP6b (Fig. 6O, solid green line), though shape
recovery was not complete. Also, while the 2,606-AU mean cell
size of SKCS127-1 (Fig. 6Q, pH 7.5) decreased to 1,623 AU in the
complemented strain (Fig. 6Q, pH 7.5), this change did not repro-
duce the original size of 859 AU for wild-type E. coli (Fig. 6Q,
pH 7.5, wt).We estimated the amount of PBP6b required to effect
FIG 4 Crystal structure of PBP6bC. (A) The crystal structure of PBP6bC
is depicted as a cartoon, with secondary structure elements colored blue (-
strands), red (-helices), and white (loops). Each strand and helix is labeled.
(B) A superimposition of the active sites of PBP6bC (white) and E. coli PBP5
(EcPBP5) (PDBid 1NZO; cyan); labels correspond to the PBP6b sequence.
(Continued)
Figure Legend Continued
Residues within 6 Å of the nucleophilic Ser42 are shown as sticks. (C) Differ-
ential scanning fluorimetry of PBP6b at pH 5.0 and 7.4 revealed a 16°C differ-
ence in Tm at the 2 pH values.
TABLE 2 Kinetic parameters of PBP6b with the substrate diacetyl-L-
Lys-D-Ala-D-Ala
pH Km (mM)
Vmax
(mol · min1 · mg1) kcat (s1)
5.0 1.57 0.34 2.27 0.25 1.57 0.17
7.5 28.6 1.90 1.35 0.15 0.93 0.10
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this change by using an enzyme-linked immunosorbent assay
(ELISA) to detect the amount of fluorescently labeled PBP6b
(sfGFP-PBP6b) (44). Roughly 12,000 to 15,000 molecules of
sfGFP-PBP6b per cell were required to produce a more normal
rod-shapedmorphology in the absence of PBP5 (data not shown).
For comparison, there are 800 to 4,000 molecules of PBP5 per cell
under similar conditions (41, 45). Thus, although PBP6b was less
active at pH 7.5, producing PBP6b in sufficient quantity could
partially compensate for the loss of PBP5 at this pH.
To put the results reported above in better perspective, we
expressed PBP5 and PBP6a in mutants lacking PBP5, to compare
the effects of these closely related enzymes with those produced by
PBP6b. As expected (21), at pH 7.5, supplying PBP5 in trans re-
turned strain SKCS127-1 to almost normal morphology (Fig. 6D;
Fig. 6O, solid blue line; and Fig. 6Q, 5), but supplying wild-type
PBP6a had no effect (Fig. 6F; Fig. 6O, solid purple line; and
Fig. 6Q, 6). These results are consistent with reports that PBP5 is
an active DD-CPase whereas PBP6a has little or no such activity
(38, 44). Supplying PBP5 to SKCS127-1 at pH 5.0 did produce a
more uniform population of rod shaped cells (Fig. 6K), but these
cells were wider than normal, and the mean cell size increased to
3,619 AU (Fig. 6Q, pH 5.0, 5). Thus, at pH 5.0, PBP5 did not
restore wild-type morphology to SKCS127-1. Ectopic PBP6a nei-
ther suppressed nor enhanced the shape defects of this mutant
(Fig. 6M; Fig. 6P, solid purple line; and Fig. 6Q), consistent with
this PBPhaving little or noDD-CPase activity. Thus, neither PBP5
nor PBP6a could substitute for the absence of PBP6b in cells
grown at pH 5.0.
Finally, we determined if PBP6b needed to be enzymatically
active to correct the morphological abnormalities of cells lacking
PBP5. In a PBP5 mutant grown at neutral pH, ectopic produc-
tion of PBP6b reduces PG pentapeptide levels, whereas the enzy-
matically inactive missense variant PBP6b(S63A) has no effect
(44). Therefore, we expressed the latter protein in SKCS127-1 to
see if shape complementation required the activity of PBP6b. As
noted above, cells lacking PBP6b were misshapen at pH 5.0 (see,
FIG 5 PBP6b (DacD) promotes normal morphology at pH 5.0. (A to R) Phase microscopy of E. coliDD-CPase mutants. Single, double, or triple PBP mutants
with or without PBP6b were grown to an OD600 of 0.7 to 0.8 in Penassay broth at pH 7.5 (A to I) or pH 5.0 (J to R) and then imaged. Cells from separate visual
fields are set off by white frames. Strains: CS109 (WT), CS219-1 (PBP4 and PBP5), SKCS132-1 (PBP4, PBP5, and PBP6b), CS204-1 (PBP5 and PBP7),
SKCS133-1 (PBP5.7 and PBP6b), CS315-1 (PBP4, PBP5, and PBP7), and SKCS127-1 (PBP4, PBP5, PBP7, and PBP6b). (S and T) Histograms of cell
populations sized by flow cytometry. PBPmutants (105 cells from the experiments represented in panels A to R as described above) were grown at pH 7.5 (S) or
pH 5.0 (T) and then analyzed by flow cytometry. The mean forward scatter area was plotted for each cell in the population. Each peak corresponds to the overall
distribution of a single strain. Individual peakswere overlaid by using FlowJo software. Green peaks represent the immediate parent strain for each of thePBP6b
mutants, which are graphed in red. (S) The vertical black dashed line provides a visual reference point for the mean cell size of the wild-type population. (T) The
dashed arrows indicate the deviation in cell size between a parent and its cognate PBP6bmutant. (U)Quantification of the shape defects for PBP6bmutants. The
shape defects of mutants (shown in panels A to R) were analyzed by flow cytometry as described for panels S and T. The mean cell sizes at pH 7.5 and pH 5.0 are
represented by the mean of the forward scatter area and are reported in arbitrary units (A.U).
Peters et al.
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e.g., Fig. 6H and P, solid green line), but expressing inactive
PBP6b(S63A) in transmade these cells evenmore aberrant (Fig. 6J
and P, dotted red line), with the mean cell size increasing from
3,028 to 4,219 AU (Fig. 6Q). The increase in shape diversity was
even greater in cells expressing the enzymatically inactive
PBP5(S44G) variant (Fig. 6L and P, dotted blue line), and the
mean size of these cells reached 5,549 AU (Fig. 6Q, pH 5.0). This
PBP5(S44G) effect was evenmore pronounced at pH 7.5 (Fig. 6E;
Fig. 6O, dotted blue line; and Fig. 6Q). In contrast, the inactive
variant PBP6a(S66A) had no effect on morphological diversity at
either pH 7.5 or pH 5.0 (Fig. 6N; Fig. 6O and P, dotted purple line;
and Fig. 6Q). Thus, expressing inactive forms of PBP6b or PBP5
failed to restore wild-type shape to cells lacking PBP5 and instead
exacerbated their morphological defects. The results confirmed
that enzyme activity was a primary cause of cell shape deficiencies.
Altogether, the results described above establish that at pH 5.0,
active PBP6b is required to produce E. coli cells of wild-type shape.
Furthermore, under these conditions, neither PBP5 nor PBP6a
could fully substitute for PBP6b.
DISCUSSION
The single-layered PG sacculus of E. coli needs to be enlarged and
remodeled to allow cell growth; these processes take place in the
periplasm and are therefore affected by environmental conditions
such as the concentration of osmolytes and ions or the external
pH. Hence, the PG synthesis and remodeling systemmust be suf-
ficiently robust to function under different conditions. PG synthe-
sis and hydrolysis are achieved by a multitude of enzymes (4). For
example, E. coli has as many as 26 periplasmic PG hydrolases,
including 8 DD-CPases, 6 DD-endopeptidases, 4 MurNAc-L-Ala
amidases, and 8 lytic transglycosylases (46). The reason for this
redundancy of PG hydrolases is not well understood.
Dissecting enzyme function in redundant pathways. In pro-
cesses with high redundancy, such as PG hydrolysis, it can be
challenging to dissect the individual roles for each component.
Chemical genomics screens canmeasure the fitness phenotypes of
single mutants under hundreds of different growth conditions,
revealing the most important genes, but system redundancy may
FIG 6 Functional PBP6b is required to maintain cell shape at pH 5.0. (A to N) Phase images of complementation with DD-CPases. An E. coli mutant lacking
PBP4, PBP5, PBP7, and PBP6b (SKCS127-1) carried plasmid pBAD vector (A and H), PBP6b (B and I), PBP5 (D and K), or PBP6a (F andM) or a plasmid
encoding the corresponding inactive mutant proteins: PBP6b(S63A) (C and J), PBP5(S44G) (E and L), or PBP6a(S66A) (G and N). Each strain was grown
overnight in Penassay broth at pH 7.5 (A to G) or pH 5.0 (H to N) and diluted into fresh medium. Wild-type proteins or their inactive mutant versions were
induced by adding 0.2% arabinose. Cultures were incubated to anOD600 of 0.7 to 0.8, harvested for flow cytometry, and imaged. Cells from separate visual fields
are set off by white frames. (O and P) Histograms of cell populations sized by flow cytometry. Strains represented in panels A to N (105 cells each) were grown
at pH 7.5 (O) or pH 5.0 (P) and then analyzed by flow cytometry. Themean forward scatter area was plotted for each cell in the population. Each graph represents
the overall distribution of a single strain as indicated. Individual peakswere overlaid by using FlowJo software. Continuous lines represent complementationwith
the active version of the respective PBPs. Dashed lines represent complementation with the inactive version of the respective PBPs. Colors represent the
individual proteins as follows: red, PBP6b; blue, PBP5; purple, PBP6a. (Q) Quantification of shape defects for complemented strains. Complementation by
wild-type andmutant PBPs was analyzed by flow cytometry. Themean cell sizes at pH 7.5 and pH 5.0 are represented by the forward scatter area and are reported
in arbitrary units (A.U).
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prevent function determination for minor genes (32). To better
understand the role of redundant genes, the corresponding pro-
teins can be purified and their activitymeasured under conditions
similar to that encountered in the cell, but this approach does not
take into account the growth condition-dependent variation of
other factors such as protein copy number, macromolecular in-
teractions and crowding, and turnover rates, all of which are usu-
ally unknown or poorly modeled. Here, we have characterized the
highly redundant PG DD-CPase system under two sets of condi-
tions by quantifying the pentapeptides in PG as a proxy for total
cellular DD-CPase activity. The statistical analysis of the PG com-
position of 28 single and multiple mutant strains permitted an
estimate of the contribution of each DD-CPase in the cell under
two different pH conditions (discussed below).
Our approach can potentially unravel the roles of other redun-
dant PG enzymes. For example, analyzing the PG composition of
multiple LD-transpeptidase mutants grown under various condi-
tions could determine the contribution of each in the formation of
3-3-crosslinks (47) and the attachment of Braun’s lipoprotein
(Lpp) (48). In the case of lytic transglycosylases, which produce
1,6-anhydroMurNAc-containing muropeptides, the PG of mu-
tants lacking multiple enzymes has been analyzed previously, but
the PG was isolated from cells grown under standard laboratory
conditions (49). It is known that the purified membrane-bound
lytic transglycosylase MltA has a pH optimum of 5.2 and higher
activity at 30°C than at 37°C (50). Hence, quantifying 1,6-
anhydroMurNAc-containing muropeptides in the PG of (multi-
ple) mutant strains grown under different conditions could help
to link the activities of individual lytic transglycosylases to partic-
ular growth conditions.
Redundancy of PGDD-CPases inE. coli.Wehave determined
in this study the prominent role of PBP5 at near neutral pH and
showed that other DD-CPases can, to some extent, complement
the loss of PBP5 at this pH. However, when cells were grown at
acidic pH, PBP5 had only negligible activity and, presumably, cel-
lular function. PBP6b, which has a minor role at pH 7.5, provided
the main DD-CPase activity at pH 5.0 (see Fig. S1 and S2 in the
supplemental material). The key role of PBP6b at low pH was
consistent with its in vitro enzyme activity (Fig. 3) and stability
(Fig. 4). PBP1B made a minor contribution to total DD-CPase
activity in cells grown at acidic pH (see Fig. S1C), consistent with
its activity in vitro (17). The approach utilized here could be ap-
plied to other growth variables (e.g., osmolarity, temperature,me-
dium composition) to determine if other DD-CPases are special-
ized for specific growth conditions. On the basis of our results and
of previously published data, we propose that E. coli maintains a
set of at least eight DD-CPases to ensure that sufficient activity is
available across the vast gamut of conditions that support growth
of this bacterium. Furthermore, PBP6a appears to be a special case
within the family of DD-CPases; consistent with its low activity in
vitro (38), PBP6a did not contribute significantly to the removal of
pentapeptides but rather seemed to protect these from cleavage by
other DD-CPases in the cell. Hence, it remains to be elucidated
whether PBP6a becomes active only under a particular set of
growth conditions or whether it has a cellular function different
from those of the other DD-CPases.
PBP6b is a specialist DD-CPase for growth at acidic pH. The
PBP6b gene, dacD, was poorly expressed when cells were grown at
pH 7.5 (Fig. 2A), consistent with a protein synthesis rate of well
below 50 copies per generation (32). This low cellular concentra-
tion and the relative instability of the protein near neutral pH
likely explainwhy the levels of PBP6b in cells grown at pH7.5were
too low for detection (Fig. 2B). That PBP6b has no major role at
pH 7.5 is consistent with the lack of a phenotype upon deletion of
dacD. However, PBP6b is activated onmultiple levels at acidic pH:
the protein is expressed at higher levels in the cell (Fig. 2B), has
higher specific activity against pentapeptide substrates (Fig. 3C),
and has higher thermostability (Fig. 4). The increased enzyme
activity is due to the 18-fold-lowerKm at acidic pH than at neutral
pH and is consistent with the stronger binding (Table 2) of the
substrate analog Bocillin (Fig. 3B). The crystal structure of PBP6b
has also been determined (Fig. 4), but comparing the highly con-
served active sites of PBP5 and PBP6b does not explain the pH
dependency of substrate binding. The only amino acid difference
between PBP6b and PBP5within ~9 Å of the nucleophile is Asn39
in PBP6b, which is an aspartate in PBP5. Based on thermostability
data, it would appear that PBP6b becomes destabilized and loses
activity at neutral pH, probably due to partial protein unfolding,
which does not occur so readily in PBP5. Considering the high
redundancy of DD-CPases, most of which are active under other
conditions, it could be beneficial for cells growing at pH 7.5 to
keep the number of PBP6bmolecules low by poor expression and
protein unfolding/degradation, ensuring that other DD-CPases
are not affected by the poor activity of the enzyme.
DD-CPase activity is required for proper cell morphology.
Newly made PG is rich in pentapeptide donor peptides, but these
are rapidly trimmed by DD-CPases to tetrapeptides (51, 52). Tet-
rapeptides cannot function as donors for transpeptidation reac-
tions by class A and B PBPs but are donors for LD-transpeptidases
which produce 3-to-3-(LD-)cross-links and covalently attach Lpp
to PG in E. coli. Many DD-CPase mutants have increased penta-
peptide content in their PG, and 3-3-crosslinks and attached Lpp
levels are both reduced (44, 47, 48); these changes are paralleled by
morphological defects, including altered cell diameter and kinked
and even branching of cells. Why the absence of DD-CPase activ-
ity leads to these defects is not known. Since LD-transpeptidase and
Lpp mutants have normal, rod-shaped morphologies, it is likely
that the DD-CPase mutant phenotypes are caused by an effect on
class A and B PBPs or indirectly by altering the geometry of the
septal ring (44). Presumably, the PG synthases or one of their
regulators functions improperly when the PG layer has elevated
pentapeptide levels, causing malfunctioning or dislocation of the
PG synthesis machinery and resulting in the loss of normal cell
morphology. As shown in this work, morphological defects can
develop in DD-CPase mutants growing at standard or low pH,
indicating that the underlying mechanism is not pH dependent.
Hence, our data suggest that DD-CPase activity is required for
robust growth with normal morphology under different growth
conditions, which is the reason why E. colimaintains a redundant
set of DD-CPases.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. Bacteria and plas-
mids used in this study are listed in Table S2 in the supplemental material
Strainswith the prefix “SKCS”were constructed for this work; strainswith
the prefix “CS” were described previously (28, 53). All experiments were
carried out at 30°C unless otherwise noted. Overnight cultures were
grown in LB and then diluted 1:300 into fresh antibiotic medium (AM3;
Difco), also known as Penassay broth. Kanamycin (50 g/ml) was in-
cluded when needed.
Peters et al.
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Microscopy. Microscopy was performed with a Zeiss Axio-Cam mi-
croscope. Cells (100 l) were harvested, pelleted, and resuspended in
10 l of growth medium. A cell suspension (5 l) was spotted onto an
agarose-coated glass slide, the sample was covered with a glass coverslip,
and the cells were allowed to settle for 5 to 10 min before imaging.
SDS-PAGE and Western blotting. Wild-type E. coli and DD-CPase
mutant strainswere grownovernight in LBbefore dilution at 1:300 into 50
ml of Penassay broth buffered to either pH 5.0 or pH 7.5. Cell growth was
monitored until cultures reached an optical density at 600 nm (OD600) of
0.7 to 0.8, at which time the cells were harvested by centrifugation at
10,000 rpm for 10 min at 4°C, in a Sorvall benchtop centrifuge. The cell
pellet was resuspended in 10 ml of filter-sterilized 25 mM citric acid-
sodium phosphate buffer (pH 5.0 or pH 7.5, as required) containing Halt
protease inhibitor (Pierce) (10 l Halt for every 10 ml of resuspended
sample) and DNase (4 g/ml final concentration). Cells were lysed by
using a low-volume, high-shearMicrofluidizer LV1 cell disruptor (Micro-
fluidics, Westwood, MA), and cell debris was removed by centrifugation
at 10,000 rpm for 10 min at 4°C. The supernatant was collected and de-
noted the total protein extract. Cell membranes were collected from ap-
proximately half of the total protein extract by ultracentrifugation in a
Beckman Coulter ultracentrifuge, using a TLA110 rotor, for 1 h at
100,000 rpm at 4°C. The supernatant was stored at 4°C. The membrane
pellet was resuspended carefully in 100 l of the appropriate citric acid-
sodiumphosphate buffer containingHalt. Proteins in themembrane frac-
tion were quantified with aMicro bicinchoninic acid (BCA) protein assay
(Pierce), according to the manufacturer’s protocol. Proteins from the
membrane fraction (10 g) were mixed with 1 Laemmli buffer, boiled
for 10 min, and loaded onto a 12% Mini-Protean TGX SDS-PAGE gel
(Bio-Rad). The gel was electrophoresed at 100 V for 30min, at which time
the voltage was increased to 120V until the dye front ran off the bottomof
the gel.
For Western blotting, protein bands from the SDS-PAGE gel were
transferred to a 0.45-m-pore-size polyvinylidene difluoride membrane
(Millipore) prewetted with methanol. The membrane was rinsed twice
(5 min each time) with fresh TBS-T buffer (per liter: 3 g Tris base, 14.4 g
glycine, 200 ml methanol, 1 ml Tween 20) and then blocked with 5%
nonfat milk–TBS-T for 1 h. The membrane was washed three times with
TBS-T for 10 min each time and then labeled with mouse anti-FLAG
antibody (Cell Signaling), diluted 1:1,000 in TBS-T–5% bovine serum
albumin (BSA), and incubated overnight at 4°C. The membrane was
washed in TBS-T three times for 5 min each time and then flooded with a
1:2,000 dilution of anti-mouse horseradish peroxidase (HRP)-linked sec-
ondary antibody (Cell Signaling)–5%nonfatmilk and incubated for 1 h at
4°C. Following three 5-min washes in TBS-T, the membrane was placed
on a stretched sheet of clear plastic wrap, coated with Advansta Western-
Bright ECL HRP substrate (Bioexpress), incubated for 5 min at room
temperature, and then developed. Fresh substrate was prepared for each
assay by mixing with 2 ml of each of the two detection reagents.
Expression and purification of PBP5 and PBP6b. DNA encoding
E. coli PBP6b residues 22 to 388 and PBP5 residues 1 to 370 (signal se-
quences were replaced by a thrombin-cleavable N-terminal oligohistidine
tag) was amplified by PCR and cloned into pET28a() (Novagen) for
overproduction of recombinant proteins. The resulting plasmids (phis-
DACD and pDACAhis [34]) were verified by sequencing. The PBPs were
produced in E. coli BL21(DE3) cells grown overnight at 30°C in 1 liter of
autoinduction medium (LB medium supplemented with 0.5% glycerol,
0.05% glucose, and 0.2% -lactose). Cells were harvested by centrifuga-
tion for 20 min at 6,200  g and 4°C. The cell pellet was resuspended in
60 ml buffer I (25 mM Tris-HCl, 100 mM NaCl; pH 8.0 for PBP6b or
pH 7.5 for PBP5). DNase, protease inhibitor cocktail (Sigma-Aldrich)
(1:1,000 dilution), and 100 M phenylmethylsulfonyl fluoride (Sigma-
Aldrich) were added before the cells were lysed by sonication and centri-
fuged for 1 h at 130,000 g and 4°C. The pellet was resuspended in 20ml
of high-salt buffer II (25 mM Tris-HCl, 10 mMMgCl2, 1 M NaCl, 0.02%
NaN3, 20% glycerol; pH 8.0 for PBP6b, pH 7.5 for PBP5) using a hand
homogenizer and incubated with continuous stirring for 2 h at 4°C. The
sample was centrifuged for 1 h at 130,000  g and 4°C. ForPBP6b, the
extracted supernatant (NaCl extract) was added to 3 ml of nickel-
nitrilotriacetic acid (Ni-NTA) Superflow (Qiagen) that had been pre-
equilibrated in buffer II. For PBP5, the pellet was resuspended in 15 ml of
extraction buffer (25 mM Tris-HCl, 10 mM MgCl2, 1 M NaCl, 0.02%
NaN3, 2%Triton X-100; pH 7.5) and stirred overnight at 4°C. The sample
was clarified by centrifugation for 45 min at 130,000 g and 4°C, and the
supernatant (Triton extract) was added to 3 ml of Ni-NTA Superflow
(Qiagen) that had been preequilibrated in extraction buffer. For both
proteins, the resin was incubated with protein extract for 1.5 h at 4°C with
gentle stirring. The resin was poured into a gravity flow column and
washed 10 times with 5 ml of buffer II (PBP6b) or extraction buffer
(PBP5), both supplemented with 5 mM imidazole, before eluting with
buffer II (PBP6b) or extraction buffer (PBP5), both supplemented with
500 mM imidazole.
Eluted proteins were dialyzed into dialysis buffer I (25 mM Tris-HCl,
1MNaCl, 10 mMEDTA; pH 8.0 for PBP6b or pH 7.5 for PBP5). Throm-
bin (Novagen) (restriction grade; 10 l for a 10-ml protein sample) was
added, and the mixture was incubated for 16 h at 4°C to cleave the
N-terminal His6 tag. After 16 h, a further 10-l aliquot of thrombin was
added per 10 ml sample and incubated for a further 8 h. The successful
removal of the His6 tag was verified by SDS-PAGE and Western blot
analysis using monoclonal mouse anti-His-tag antibody (Sigma). Pro-
teins were dialyzed stepwise into dialysis buffer II (10mMsodium acetate,
10 mM MgCl2, 500 mM NaCl, 0.02% NaN3; pH 5.0) and diluted 1:5 in
buffer C (10°mM sodium acetate, 10 mM MgCl2, 0.02% NaN3; pH 5.0
[for PBP5, 0.8% Triton X-100]). Proteins were further purified by cation
exchange chromatography using a 5ml HiTrap SPHP column and eluted
using a gradient from 100mM to 1MNaCl. Eluted proteins were dialyzed
into dialysis buffer III (25 mM sodium acetate, 10 mM MgCl2, 0.02%
NaN3, 10% glycerol, 1 M NaCl; pH 5.0). PBP6b was concentrated and
further purified by size exclusion chromatography using a HiLoad 16/600
Superdex 200-pg column and dialysis buffer II. Afterward, PBP6b was
dialyzed into dialysis buffer III (25 mM sodium acetate, 10 mm MgCl2,
1 M NaCl, 10% glycerol, 0.02% NaN3), flash-frozen in liquid nitrogen,
and stored until further use at80°C.
Purification of PBP6bC. For structural studies, the DNA coding for
residues 1 to 353 of PBP6B, which thus lacked both the signal peptide and
the C-terminal amphipathic helix, was cloned by PCR into a modified
pET15bderivative that encoded a tobacco etch virus (TEV)-cleavableHis6
tag at the N terminus of the encoded protein, PBP6bC. The overexpres-
sion plasmid was transformed into E. coli BL21(DE3) and grown at 37°C.
Once the culture had reached anOD600 of 0.5 to 0.7, PBP6bC expression
was induced with 1 mM IPTG (isopropyl--D-thiogalactopyranoside)
and the culture was grown for a further 21 h at 22°C. The cell culture was
harvested by centrifugation, and the pellet was resuspended in a buffer
consisting of 50mMTris-HCl (pH 7.5), 500mMNaCl, 20mM imidazole
supplemented with one EDTA-free protease inhibitor tablet (Roche), and
DNase I to reach a final concentration of 4 g/ml. The cells were lysed
using a One Shot cell disruptor (Constant Systems) at 172 MPa, and the
cell debris was removed by centrifugation (40,000 g at 4°C for 30 min).
The supernatant was applied to an Ni-charged HisTrap FF column (GE
Healthcare) preequilibrated in 50 mMTris-HCl (pH 7.5), 500 mMNaCl,
20 mM imidazole. After loading the sample, the column was washed with
a buffer consisting of 50 mM Tris-HCl (pH 7.5), 500 mM NaCl, and
20 mM imidazole before the bound proteins were gradient eluted against
increasing imidazole concentrations from a buffer consisting of 50 mM
Tris-HCl (pH 7.5), 500 mM NaCl, and 800 mM imidazole. The His6 tag
was removed by overnight TEV cleavage (1 g TEV per mg PBP6bC)
prior to size exclusion chromatography performed using a Superdex 75
HiLoad 16/60 column (GEHealthcare) equilibrated in a buffer consisting
of 25mMTris-HCl (pH 7.5) and 150mMNaCl. The purified protein was
flash-frozen in liquid nitrogen and stored at80°C.
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Crystallization and X-ray crystallography of PBP6bC. For crystal-
lization, purified PBP6bC was lysine methylated overnight according to
the instructions of the manufacturer (Jena Biosciences). This sample was
subsequently loaded onto a Superdex 75 HiLoad 16/60 column (GE
Healthcare) equilibrated in a buffer consisting of 25 mM Tris-HCl
(pH 7.5), 150 mM NaCl, and 5 mM dithiothreitol (DTT). The proteins
that eluted in the void fraction were separated from those that eluted as a
monomer and discarded, and the remaining fraction was concentrated to
13 mg/ml. The pseudosubstrate diacetyl-L-Lys-D-Ala-D-Ala was added to
reach a 2 mM final concentration before 100-nl sitting-drop vapor diffu-
sion commercial crystallization screens were set up with aMosquito (TTP
Labtech) pipetting robot. Crystals took 3 months to grow in a crystalliza-
tion solution consisting of 20%polyethylene glycol (PEG) 3000 and 0.1M
sodium citrate (pH 5.5), and the PBP6bC crystals were cryoprotected by
adding 25% PEG 400 to the mother liquor before flash-freezing in liquid
nitrogen was performed. Diffraction data were collected on beamline I02
of theDiamond synchrotron light source, indexed inXDS (54), and scaled
and reduced inAIMLESS (55). The crystals belong to space groupP1, with
two molecules of PBP6bC in the unit cell. The structure was solved by
molecular replacement using PHASER (56) and the structure of E. coli
PBP5 (PDBid 1NZO[37]) as the searchmodel. The structure of PBP6bC
was refined in REFMAC5 (57) interspersed with rounds of manual re-
building in COOT (58) until the refinement reached convergence. Data
collection and refinement statistics are summarized in Table S3 in the
supplemental material.
Differential scanning fluorimetry.Using the fluorescent dye SYPRO
Orange (Sigma Aldrich), a thermal shift assay (59) was performed to as-
sess the thermal stability of PBP6bC at pH 5.0 and pH 7.5. Solutions of
PBP6b and PBP6bC at a 1 M concentration in the presence of 5
SYPRO Orange were prepared at the desired pH (using citric acid or
sodium phosphate buffer), and 40 l of each solution was added to thin-
wall PCR tubes. The tubes were heated in a Rotor Gene 6000 quantitative
PCR (qPCR) machine (Corbett Life Sciences) from 25°C to 99°C at a rate
of 1°C permin. Fluorescence changes weremonitoredwith excitation and
emission wavelengths of 492 and 610 nm, respectively. Tm values were
compared for each sample, with a higher Tm indicative of higher thermal
stability. The experiments were carried out in triplicate, and nonlinear
regression analysis was performedwith Rotor Gene 6000 proprietary soft-
ware.
Bocillin-binding assay. The activity of PBP6b was tested in an assay
using the fluorescent penicillin V derivate Bocillin-FL (Life Technologies)
(60). Ten micrograms of PBP6b was incubated with 1 ng/l of bocillin at
37°C. Reactions were performed in the presence of 10 mM MgCl2 at
pH 5.0 (10 mM sodium acetate) and pH 7.5 (10 mM HEPES). Samples
were taken after 0, 0.5, 1, 2, 5, 10, 15, 30, and 40 min; the reactions were
stopped by addition of 4 SDS-PAGE sample buffer and by boiling for
30 min at 100°C. The proteins were separated by 12% SDS-PAGE before
the bocillin-PBP complexes were detected with a GEHealthcare Typhoon
laser scanner (excitation laser, 488 nm; emission filter, 520 nm BP 40;
photomultiplier tube [PMT] voltage, 600 V), and proteins were subse-
quently stained with Coomassie blue.
Activity of PBP6b andPBP5 against PG. PBP6b and PBP5were incu-
bated at different concentrations (0.01, 0.03. 0.1, 0.3, or 1 M) with
pentapeptide-rich PG from E. coli CS703/1 or at a concentration of
0.3 M with glycine and pentapeptide-rich sacculi from C. crescentus
CB15N. The reactions were performed for 1 h in a Thermomixer at 37°C
and 700 rpm in a total volume of 50 l and buffered either at pH 7.5
(25 mM HEPES, 10 mM MgCl2, 150 mM NaCl) or at pH 5.0 (25 mM
sodium acetate, 10 mM MgCl2, 150 mM NaCl). The enzymes were inac-
tivated by boiling for 10 min at 100°C. The samples were digested with
cellosyl at 37°C and 700 rpm overnight, followed by heat inactivation for
10 min at 100°C. The samples were centrifuged for 15 min at 17.000 g.
The muropeptides present in the supernatant were reduced with sodium
borohydride and separated by HPLC according to published procedures
(61). Muropeptide profiles were quantified with Laura software (Lab
Logic Systems Ltd.).
Spectrophotometric D-alanine release assay for E. coli PBP6b DD-
carboxypeptidase activity. The DD-CPase activity of PBP6b under dif-
ferent pH conditions was determined by a modified spectrophotometric
assay (62) which measures the release of D-alanine, using a Biochrom
Libra S22 UV-visible light (UV/Vis) spectrophotometer and matched
quartz cuvettes (Starna Scientific Ltd.) (path length, 10 mm). The sub-
strate diacetyl-L-Lys-D-Ala-D-Ala was kindly provided by Mohammed
Terrak, University of Liege. In this assay, the D-amino acid oxidase
(DAAO; Sigma Aldrich) deaminates the released D-alanine, generating
pyruvate and hydrogen peroxide. The latter is reduced to H2O by horse-
radish peroxidase (HRP, Sigma Aldrich) using Amplex Red (Invitrogen)
as an electron donor, producing resorufin, which can be quantified spec-
trophotometrically at 563 nm. Because the published continuous assay
did not work at pH 5.0, we modified the assay protocol for endpoint
measurements. For this, 1 M PBP6b was incubated at 37°C in a final
volume of 500l using 50mM sodium acetate (pH 5.0) or 50mMHEPES
(pH 7.5) with various concentrations of diacetyl-L-Lys-D-Ala-D-Ala. After
different time periods, 50-l samples were withdrawn from the sample
and the reactions were stopped by boiling for 20 min at 100°C. After a
short centrifugation step for 5 min at 17.000  g was performed, the
samples were stored at 20°C until further use. The released D-alanine
was quantified by adding the withdrawn sample to 200 l of a mixture
consisting of 50 mM HEPES-NaOH, 10 mM MgCl2 (pH 7.5), 50 M
Amplex Red, 75.5 g/ml DAAO, and 54.5 g/ml HRP. Samples were
incubated for 60 min at 37°C, and the absorbance at 563 nm was mea-
sured. Standard samples contained D-alanine at known concentrations.
The kinetic constants Km and Vmax corresponding to the CPase activ-
ity of PBP6bwere calculated using GraphPad Prism 6 software. The initial
velocities of PBP6b CPase activity versus substrate concentrations were
fitted by nonlinear regression to equation 1:
V0
Vmax S
KmS
Peptidoglycan isolation and analysis.Penassy broth (Difco antibiotic
medium 3) adjusted to pH 5.0 or 7.5 with maleic acid or NaOH was used
for growing cells to an OD578 of 0.6 at 30°C. The pH value did not change
during growth. PG was prepared and analyzed according to a method
published previously (61).
Flow cytometry. Wild-type E. coli and the DD-CPase mutants were
grown overnight in LB at 30°C. The cells were diluted 1:300 into 5 ml of
Penassay broth buffered at pH 5.0 or pH 7.5. Cells were grown until the
OD600 reached 0.7 to 0.8, and cells from 1 ml of culture were pelleted by
centrifugation, washed twice, and then diluted 1:20 into filter-sterilized
25 mM citric acid-sodium phosphate buffer at the appropriate pH. Cells
were analyzed by using a BD LSRFortessa flow cytometer (BD Biosci-
ences), housed in the University of Arkansas for Medical Sciences
(UAMS) flow cytometry core.
Statistical analyses.Multivariable linear regressionmodels were fitted
to estimate the association between the presence or absence of each PBP
(coded as a 0/1 predictor variable) and the resulting muropeptide level
(i.e., the response variable). The coefficient estimates from these models
represent the influence of each PBP mutant on the amounts of each mu-
ropeptide.
Protein structure accession number. Atomic coordinates and struc-
ture factors have been deposited at the PDB with accession code 5FSR.
SUPPLEMENTAL MATERIAL
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